← Leaderboards
Zhao Zhang
Ut Southwestern Medical Center
$3,642,127
Attributed
$3,642,127
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,642,127 · 6
By mechanism
R01$1,392,688 · 1
P01$869,939 · 2
R00$747,000 · 1
R21$451,000 · 1
K99$181,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Abhimanyu Garg$28,553,253
- Russell Alfred Debose-Boyd$14,724,021
- Lucienne Chatenoud$1,755,880
Others in their field
Other Emerging Leaders on “Phenotype”
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,463,085
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$28,580,688
- Evan Z Macosko · Broad Institute, Inc.$28,218,682
- Badri N Vardarajan · University Of Miami School Of Medicine$23,982,327
Research focus
PhenotypeGenesGeneticInsulin ResistanceKnock-OutMetabolicProteinsNew Therapeutic TargetMutant Strains MiceRegulationInsightGenetic ScreeningFatty LiverTissuesMass Spectrum AnalysisIn VitroMutationPathogenesisPrevalenceGenetic TranscriptionOverexpressionLipidsLiverMouse Model
Grant awards (12)
Core C - Mutagenesis, Screening and Cryopreservation$608,220
P01 · FY2025 · AI · contact PI
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease$324,720
R01 · FY2025 · DK · contact PI
Project 1 - Immunologic and Cellular Mechanisms of T1D Modifier Mutations$261,719
P01 · FY2025 · AI · contact PI
The Role of KBTBD2 in Bone Development and SHORT Syndrome$451,000
R21 · FY2024 · HD · contact PI
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease$346,368
R01 · FY2024 · DK · contact PI
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease$360,800
R01 · FY2023 · DK · contact PI
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease$360,800
R01 · FY2022 · DK · contact PI
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes$249,000
R00 · FY2022 · DK · contact PI
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes$249,000
R00 · FY2021 · DK · contact PI
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes$249,000
R00 · FY2020 · DK · contact PI
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes$90,000
K99 · FY2018 · DK · contact PI
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes$91,500
K99 · FY2017 · DK · contact PI